How many people are employed at Y-mAbs Therapeutics A/S?

43 people are employed at Y-mAbs Therapeutics A/S.

Where is Y-mAbs Therapeutics A/S based?

Y-mAbs Therapeutics A/S is based in Hørsholm, Denmark.

When was Y-mAbs Therapeutics A/S founded?

Y-mAbs Therapeutics A/S was founded in 2015.

What is Y-mAbs Therapeutics A/S's website?

You can visit Y-mAbs Therapeutics A/S's website at https://ymabs.dk.

Y-mAbs Therapeutics A/S

37053678Active

Developing innovative radioimmunotherapy and antibody-based treatments for challenging cancers.

Biopharmaceutical companyymabs.dk

43
Employees: Unknown
Revenue: 2015
Founded

Y-mAbs Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapies. The organization specializes in treating challenging, life-threatening diseases, particularly in the field of oncology. They are known for the...

Keywords

Antibody-based TherapyBiopharmaceuticalBiotechnologyCancer TreatmentClinical TrialsDANYELZADrug DevelopmentHealthcareLife SciencesMedical InnovationNaxitamabNeuroblastomaOncologyPediatric OncologyPharmaceutical ResearchRadioimmunotherapyRare DiseasesSERB PharmaceuticalsTherapeutic SolutionsY-mAbs Therapeutics

Tech Stack

jQueryBootstrapWordPressTrustArcreCAPTCHAGoogle AnalyticsWooCommerce

Decision Makers

No decision makers found yet

Similar Companies

20 similar companies in Funnelfeedr

GENMAB A/S

562 employees

Pioneering biotechnology company developing innovative antibody therapeutics for serious diseases.

Servier Symphogen A/S

163 employees

Advancing innovative antibody therapeutics to improve cancer patient outcomes globally.

Jazz Pharmaceuticals Denmark ApS

12 employees

Global biopharmaceutical company developing innovative medicines for rare diseases.

CHIESI PHARMA AB

International biopharmaceutical group focused on patient care and innovation.

ASCENDIS PHARMA A/S

608 employees

Global biopharmaceutical company developing innovative therapies using proprietary TransCon technology.